Showing results (1-10 of 652) with videos related to
Sort By:
Pageof 66
Journal of Biopharmaceutical Statistics|July 31, 2026
A phase II, seamless single-arm to two-arm Bayesian design for a time-to-event endpointYun Qing, Ruitao LinBiometrics|June 6, 2018
Bayesian optimal interval design with multiple toxicity constraintsRuitao LinJournal of Biopharmaceutical Statistics|July 2, 2019
On the relative efficiency of model-assisted designs: a conditional approachRuitao Lin, Ying YuanContemporary Clinical Trials|July 28, 2015
Bayes factor and posterior probability: Complementary statistical evidence to p-valueRuitao Lin, Guosheng YinStatistics in Medicine|August 9, 2017
STEIN: A simple toxicity and efficacy interval design for seamless phase I/II clinical trialsRuitao Lin, Guosheng YinStatistical Methods in Medical Research|July 17, 2015
Bayesian optimal interval design for dose finding in drug-combination trialsRuitao Lin, Guosheng YinBiostatistics (Oxford, England)|August 24, 2016
Nonparametric overdose control with late-onset toxicity in phase I clinical trialsRuitao Lin, Guosheng YinBiostatistics (Oxford, England)|April 16, 2019
Time-to-event model-assisted designs for dose-finding trials with delayed toxicityRuitao Lin, Ying YuanPharmaceutical Statistics|August 2, 2018
Uniformly most powerful Bayesian interval design for phase I dose-finding trialsRuitao Lin, Guosheng YinStatistics in Biopharmaceutical Research|August 22, 2025
Isotonic Phase I cancer clinical trial design utilizing patient-reported outcomesNolan A Wages, Ruitao LinPageof 66